BioPhorum’s in-depth feedback includes 70 line-by-line, detailed comments, including the rationale for the points and any proposed changes/recommendations that are deemed necessary by the team to ensure a harmonized implementation across industry and regulatory agencies.
Marketing Authorization Applications
Viewing related articles
read more
Clinically relevant specifications setting benchmarking survey
Mar 2022 | Accelerate CMC Development to Marketing Application, Benchmarking, CMC Regulatory, Deliverable, Deliverables Report, Development Group
A BioPhorum member only survey gathering feedback on initial submission Biologics License Applications (BLA) / Marketing Authorization Application (MAA) supplement/variation, etc.) and the outcome of health authority review and approval of the submission.